Your browser doesn't support javascript.
loading
APOE Molecular Spectrum in a French Cohort with Primary Dyslipidemia.
Abou Khalil, Yara; Marmontel, Oriane; Ferrières, Jean; Paillard, François; Yelnik, Cécile; Carreau, Valérie; Charrière, Sybil; Bruckert, Eric; Gallo, Antonio; Giral, Philippe; Philippi, Anne; Bluteau, Olivier; Boileau, Catherine; Abifadel, Marianne; Di-Filippo, Mathilde; Carrié, Alain; Rabès, Jean-Pierre; Varret, Mathilde.
Afiliación
  • Abou Khalil Y; Laboratory for Vascular Translational Science (LVTS), Paris Cité University and Sorbonne Paris Nord University, INSERM, F-75018 Paris, France.
  • Marmontel O; Laboratory of Biochemistry and Molecular Therapeutics (LBTM), Faculty of Pharmacy, Pôle Technologies-Santé (PTS), Saint-Joseph University, Beirut 1004 2020, Lebanon.
  • Ferrières J; CarMen Laboratory, INSERM U1060, INRAE U1397, Université Lyon 1, F-69921 Oullins, France.
  • Paillard F; Department of Biochemistry and Molecular Biology, Hospices Civils de Lyon, F-69500 Bron, France.
  • Yelnik C; Department of Cardiology, Toulouse Rangueil University Hospital, UMR 1295 INSERM, F-31400 Toulouse, France.
  • Carreau V; Cardiovascular Prevention Centre, Centre Hospitalo-Universitaire, F-35033 Rennes, France.
  • Charrière S; Département de Médecine Interne et Immunologie Clinique Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO) CHU de Lille, F-59037 Lille, France.
  • Bruckert E; U1167 Risk Factors and Molecular Determinants of Aging-Related Diseases, Inserm CHU de Lille, Lille University, F-59000 Lille, France.
  • Gallo A; Department of Endocrinology and Prevention of Cardiovascular Disease, Institute of Cardio Metabolism and Nutrition (ICAN), La Pitié-Salpêtrière Hospital, AP-HP, F-75005 Paris, France.
  • Giral P; Department of Biochemistry and Molecular Biology, Hospices Civils de Lyon, F-69500 Bron, France.
  • Philippi A; Department of Endocrinology and Prevention of Cardiovascular Disease, Institute of Cardio Metabolism and Nutrition (ICAN), La Pitié-Salpêtrière Hospital, AP-HP, F-75005 Paris, France.
  • Bluteau O; Department of Endocrinology and Prevention of Cardiovascular Disease, Institute of Cardio Metabolism and Nutrition (ICAN), La Pitié-Salpêtrière Hospital, AP-HP, F-75005 Paris, France.
  • Boileau C; Department of Endocrinology and Prevention of Cardiovascular Disease, Institute of Cardio Metabolism and Nutrition (ICAN), La Pitié-Salpêtrière Hospital, AP-HP, F-75005 Paris, France.
  • Abifadel M; Institut Cochin, Bâtiment Faculté Inserm U1016, Cnrs UMR8104, Université de Paris Faculté de Médecine, F-75014 Paris, France.
  • Di-Filippo M; INSERM UMRS 1166, Faculty of Medicine Pitié-Salpêtrière, Sorbonne University, F-75005 Paris, France.
  • Carrié A; Laboratory for Vascular Translational Science (LVTS), Paris Cité University and Sorbonne Paris Nord University, INSERM, F-75018 Paris, France.
  • Rabès JP; Genetic Department, AP-HP, Hôpital Bichat, F-75018 Paris, France.
  • Varret M; Laboratory for Vascular Translational Science (LVTS), Paris Cité University and Sorbonne Paris Nord University, INSERM, F-75018 Paris, France.
Int J Mol Sci ; 23(10)2022 May 21.
Article en En | MEDLINE | ID: mdl-35628605

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Apolipoproteínas E / Proproteína Convertasa 9 / Hiperlipoproteinemia Tipo II Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Apolipoproteínas E / Proproteína Convertasa 9 / Hiperlipoproteinemia Tipo II Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza